BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 5, 2020

  Eton Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing innovative drug products, announced that it will report fourth quarter and full year 2019 financial and operating results on Thursday, March 5, 2020.

  February 27, 2020

   · 

  1 min read
• Business

  Immunomedics Appoints Robert W. Azelby to Board of Directors

  Immunomedics, Inc., a leading biopharmaceutical company in the area of antibody-drug conjugates, announced the appointment of Robert W. Azelby to the Company’s board of directors.

  February 27, 2020

   · 

  4 min read
• BioMidwest

  HIMSS20 Proceeds as ScheduledMembers of the healthcare community will convene in Orlando March 9-13

  The HIMSS Global Health Conference & Exhibition will proceed as scheduled March 9-13 in Orlando, Fla. As of February 27, 2020, registration is experiencing an upswing of 7 percent over HIMSS19 participation.

  February 27, 2020

   · 

  4 min read
• Business

  Otonomy Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

  Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, reported financial results for the fourth quarter and year ended December 31, 2019 and provided an update on its product pipeline and corporate activities.

  February 27, 2020

   · 

  15 min read
• Policy

  Stellar Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

  Stellar Health, a leading organization in value-based care, announced, that the Stellar Health Web Application and supporting infrastructure has earned Certified status for information security by HITRUST.

  February 27, 2020

   · 

  2 min read
• FDA

  Biohaven’s NURTEC™ ODT (rimegepant) Receives FDA Approval for the Acute Treatment of Migraine in Adults

  -Biohaven Pharma Holding Company Ltd. (NYSE: BHVN) today announced that the U.S. Food and Drug Administration (FDA) has approved NURTEC™ ODT (rimegepant) for the acute treatment of migraine in adults.

  February 27, 2020

   · 

  11 min read
• Business

  Five Prime Therapeutics Reports Fourth Quarter and Full Year 2019 Results

  Five Prime Therapeutics, Inc. (NASDAQ: FPRX), , today announced results for the fourth quarter and year ended December 31, 2019, in addition to providing an update on the company’s recent activities.

  February 27, 2020

   · 

  15 min read
• Business

  Tricida Announces Fourth Quarter and Full-Year 2019 Financial Results

  Tricida, Inc. (Nasdaq: TCDA) announced today financial results for the fourth quarter and full-year ended December 31, 2019.

  February 27, 2020

   · 

  10 min read
• Business

  Denali Therapeutics Reports Full Year 2019 Financial Results and Business Highlights

  Denali Therapeutics Inc. (NASDAQ: DNLI), today reported financial results for the fourth quarter and full year ended December 31, 2019, and provided business highlights.

  February 27, 2020

   · 

  9 min read
• Biotech Bay

  Varian to Attend Upcoming Investor Events in March 2020

  Varian announced that J. Michael Bruff, chief financial officer and Anshul Maheshwari, vice president, investor relations and treasurer will be participating in the following investor conferences

  February 27, 2020

   · 

  1 min read